Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 24, 2008. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific executive transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction regarding the equity interests of Mr. M Dunoyer:
- Date: December 12, 2008
- Action: Exercise of options over 816 Ordinary shares.
- Scheme: GlaxoSmithKline Savings Related share option scheme.
- Price: £11.45 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share option exercise.
Investor Verification Checklist
- Verify the total number of shares held by Mr. M Dunoyer following the exercise of 816 options.
- Confirm the market price of GSK Ordinary shares on December 12, 2008, to assess the immediate economic impact of the exercise price (£11.45).
- Review the full terms of the GlaxoSmithKline Savings Related share option scheme for vesting conditions.